Abstract:Background Approximate 7.2% Chinese have been suffered from chronic hepatitis B virus (HBV) infection manifesting positive HBsAg. Our previous study showed the positive rate of HBsAg in Chinese rheumatoid arthritis (RA) patients was 11.3% (2013, Clin Rheumatol). Screening of HBV infection prior to immunosuppressive therapy, monitoring and antiviral prophylaxis during DMARDs treatment are recommended for HBsAg(+) RA patients by ACR 2008/2012 recommendations. However, little is known about the real-world clinical practice of Chinese physicians. Objectives To investigate Chinese physicians' awareness of HBV infection in RA patients and to identify the important targets of education. Methods A cross-section survey of 100 physicians who treated RA patients in daily clinic was conducted with a modified ACR questionnaire (2010, Arthritis Care & Research). The questionnaire was composed of demographic data and 10 questions concerning essential areas of screening HBV infection, monitoring and antiviral prophylaxis (or therapy) during immunosuppressive therapy for RA patients. Each question has 4-7 options for choice. The questionnaires with ≥8 answered items were regarded as valid for statistical analysis. Results 1. 100 physicians were recruited for the survey and 92 questionnaires with ≥8 answered items were valid for statistical analysis. Among them, 73% were rheumatologist, 27% were non-rheumatologists including internal medicine physicians (14%), orthopedists (8%), traditional Chinese medical physicians (2%) and other specialists (3%). The mean working seniority was 11.3 years (range, 1-32) and 73% physicians were consulted more than 5 RA patients per month. 2. Twenty-three percentage of physicians reported no routine screening for HBV infection before immunosuppressive therapy for outpatients with RA, comparing 92% for hospitalized RA patients. During immunosuppressive therapy for HBsAg(+) RA patients, 36% physicians reported no regular monitoring of HBV DNA and 12% reported no regular monitoring of aminotransferases. Twenty-four percentage of physicians considered antiviral prophylaxis for HBsAg(+) RA patients and regarding to the detailed indications of antiviral prophylaxis, 62% (57/92) physicians considered high HBV load, 39% (36/92) considered elevated aminotransferases, and 32% (29/92) considered both HBsAg(+) and HBeAg(+). 3. Eighty-eight percentage of physicians had clinical experience of antiviral prophylaxis or therapy for RA patients. Among them, 62% prescribed antiviral drug before or at the initiation of immunosuppressive therapy and 38% prescribed antiviral drug after HBV reactivation. Conclusions Our results showed that Chinese physicians have poor awareness of HBV infection for RA patients. The further CME should emphasize the routine screening for HBV infection especially in RA outpatients, regular monitoring of HBV DNA for HBsAg(+) RA patients, and antiviral prophylaxis considered to all HBsAg(+) RA patients with immunosuppressive treatment. Acknowledgements This work was supported by Specialized Research Fund for the Doctoral Program of Higher Education (no.20130171110075) and Natural Science Foundation of Guangdong Province, China (no.S2013010014396) to L. Dai; Medical Scientific Research Foundation of Guangdong Province, China (no.A2013201) to Y-Q. Mo; Chinese National Natural Science Research Grant (Grant no. 81373183 and 81001334) to L-J. Zhu. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.4022

Low Positivity Rates for HBeAg and HBV DNA in Rheumatoid Arthritis Patients: a Case-Control Study

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Retrospective Analysis of Hepatitis B Virus Serological Markers in 70 582 Inpatients

Potential Role of Peripheral Blood Lymphocyte Subsets in Rheumatoid Arthritis Patients Concurrent with Hepatitis B Virus Infection：A Retrospective Cohort Study

[Hepatitis B Virus Infection Status and Clinical Characteristics in Patients with Rheumatoid Arthritis].

Deleterious Role of Hepatitis B Virus Infection in Therapeutic Response among Patients with Rheumatoid Arthritis in a Clinical Practice Setting: a Case-Control Study.

The Association Between Hepatitis B Virus Infection and Disease Activity, Synovitis, or Joint Destruction in Rheumatoid Arthritis

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.

Low but Long-lasting Risk of Reversal of Seroconversion in Patients With Rheumatoid Arthritis Receiving Immunosuppressive Therapy

HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Different Immune Conditions.

AB0337 Questionnaire Survey on 100 Chinese Physicians for Awareness of Hepatitis B Virus Infection in Rheumatoid Arthritis Patients

Survey on doctor's screening practice and clinical management for hepatitis B virus infection in patients with rheumatoid arthritis

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

Low Prevalence of Hepatitis B Virus Infection in Patients with Autoimmune Diseases in a Chinese Patient Population

Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.

Predictors of Inflammatory Activity in Treatment-Naive Hepatitis B E-Antigen-negative Patients with Chronic Hepatitis B Infection

Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts

Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database

Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology

Relationship Between Hepatitis B Virus Dna Levels and Liver Histology in Patients with Chronic Hepatitis B